Brain cancer patients get virus injection in new hope trial
NCT ID NCT06763965
First seen Dec 08, 2025 · Last updated May 24, 2026 · Updated 20 times
Summary
This study tests a new treatment for people with recurrent high-grade glioma, a serious brain cancer that has come back after standard therapy. The treatment uses a modified virus (oncolytic adenovirus) designed to infect and kill cancer cells while also boosting the immune system. About 30 adults will receive the virus through a special device placed in the brain, and researchers will monitor safety, side effects, and survival for 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sanbo Brain Hospital, Capital Medical University
Beijing, Chaoyang District, China
Conditions
Explore the condition pages connected to this study.